{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:30:38Z","timestamp":1786735838675,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/jcrt.jcrt_35_18","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T09:08:09Z","timestamp":1570698489000},"page":"1309","source":"Crossref","is-referenced-by-count":11,"title":["Epithelial\u2013mesenchymal transition in serous and mucinous epithelial tumors of the ovary"],"prefix":"10.4103","volume":"15","author":[{"given":"Charanjeet","family":"Ahluwalia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geet","family":"Bhuyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.268949-1","first-page":"268","volume-title":"Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer","author":"Ahmed","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"key":"key-10.4103\/0973-1482.268949-2","first-page":"33","volume-title":"Epithelial-mesenchymal transition in ovarian carcinoma","author":"Davidson","year":"2012","journal-title":"Front Oncol"},{"key":"key-10.4103\/0973-1482.268949-3","first-page":"49","volume-title":"Molecular profiling supports the role of epithelial-to-mesenchymal transition (EMT) in ovarian cancer metastasis","author":"Lili","year":"2013","journal-title":"J Ovarian Res"},{"key":"key-10.4103\/0973-1482.268949-4","first-page":"107","volume-title":"Epithelial-mesenchymal transition: Focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds","author":"Samatov","year":"2013","journal-title":"Mol Cancer"},{"key":"key-10.4103\/0973-1482.268949-5","first-page":"21","volume-title":"ESMO Guidelines Working Group.Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up","author":"Aebi","year":"2009","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0973-1482.268949-6","first-page":"818","volume-title":"Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis","author":"Yang","year":"2008","journal-title":"Dev Cell"},{"key":"key-10.4103\/0973-1482.268949-7","first-page":"415","volume-title":"Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?","author":"Peinado","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key-10.4103\/0973-1482.268949-8","first-page":"460","volume-title":"Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer","author":"Voutilainen","year":"2006","journal-title":"J Clin Pathol"},{"key":"key-10.4103\/0973-1482.268949-9","first-page":"275","volume-title":"E-cadherin expression in human epithelial ovarian cancer and normal ovary","author":"Sundfeldt","year":"1997","journal-title":"Int J Cancer"},{"key":"key-10.4103\/0973-1482.268949-10","first-page":"608","volume-title":"Cellular integrity plus: Organelle-related and protein-targeting functions of intermediate filaments","author":"Toivola","year":"2005","journal-title":"Trends Cell Biol"},{"key":"key-10.4103\/0973-1482.268949-11","doi-asserted-by":"crossref","unstructured":"Steinert PM, Roop DR. Molecular and cellular biology of intermediate filaments. Annu Rev Biochem 1988;57:593-625","DOI":"10.1146\/annurev.bi.57.070188.003113"},{"key":"key-10.4103\/0973-1482.268949-12","first-page":"2050","volume-title":"Novel functions of vimentin in cell adhesion, migration, and signaling","author":"Ivaska","year":"2007","journal-title":"Exp Cell Res"},{"key":"key-10.4103\/0973-1482.268949-13","doi-asserted-by":"crossref","unstructured":"Franke WW, Grund C, Kuhn C, Jackson BW, Illmensee K. Formation of cytoskeletal elements during mouse embryogenesis. III. Primary mesenchymal cells and the first appearance of vimentin filaments. Differentiation 1982;23:43-59.","DOI":"10.1111\/j.1432-0436.1982.tb01266.x"},{"key":"key-10.4103\/0973-1482.268949-14","first-page":"1436","volume-title":"Vimentin regulates EMT induction by slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer","author":"Vuoriluoto","year":"2011","journal-title":"Oncogene"},{"key":"key-10.4103\/0973-1482.268949-15","first-page":"515","volume-title":"A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes","author":"Neve","year":"2006","journal-title":"Cancer Cell"},{"key":"key-10.4103\/0973-1482.268949-16","first-page":"5278","volume-title":"Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis","author":"Schuetz","year":"2006","journal-title":"Cancer Res"},{"key":"key-10.4103\/0973-1482.268949-17","first-page":"1050","volume-title":"Analysis of integrin beta4 expression in human breast cancer: Association with basal-like tumors and prognostic significance","author":"Lu","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0973-1482.268949-18","first-page":"8790120","volume-title":"Clinicopathological significance of vimentin and cytokeratin protein in the genesis of squamous cell carcinoma of cervix","author":"Husain","year":"2016","journal-title":"Obstet Gynecol Int"},{"key":"key-10.4103\/0973-1482.268949-19","first-page":"970","volume-title":"Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC","author":"Zhai","year":"2014","journal-title":"Med Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:34:07Z","timestamp":1786732447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_35_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"alternative-id":["268949"],"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_35_18","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}